Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells-Reference-Cited by-同舟云学术

Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells

Published:2020-04-06 Issue:3 Volume:105 Page:577-585
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Kwon Ji-Hye,Han Sangbin,Jang Jin Sung,Lee Kyo Won,Ahn Joong Hyun,Kim Kyunga,Jeon Suyong,Gwak Mi Sook,Ko Justin S.,Kim Gaab Soo,Joh Jae-Won,Cho Duck

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference32 articles.

1. Red blood cell transfusion in clinical practice.;Klein;Lancet,2007

2. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection.;Shiba;J Gastrointest Surg,2009

3. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions.;Cata;Br J Anaesth,2013

4. Red blood cell transfusion and outcome in cancer.;Iqbal;Transfus Apher Sci,2017

5. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.;Yang;Semin Cancer Biol,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of post-storage filters vs. pre-storage filters for leukoreduction of blood components on clinical outcomes: a systematic review and meta-analysis;Systematic Reviews;2024-07-25

2. Effect of post-storage filters vs. pre-storage filters for leukoreduction of blood components on clinical outcomes: A systematic review;2024-02-28

3. Influência do momento da leucorredução de hemocomponentes na evolução clínica de pacientes transfundidos na emergência;Revista Brasileira de Enfermagem;2024

4. Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department;Revista Brasileira de Enfermagem;2024

5. Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5%;Scientific Reports;2023-08-09